Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 105192
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.105192
Figure 1
Figure 1 Comparison of apurinic/apyrimidinic endonuclease 1 autoantibodies, peripheral pentraxin-3, and miR-486-3p Levels. aP < 0.05 vs occurrence group. APE1-AAbs: Apurinic/apyrimidinic endonuclease 1 autoantibodies; PTX-3: Peripheral pentraxin-3.
Figure 2
Figure 2 Relationship of apurinic/apyrimidinic endonuclease 1 autoantibodies, peripheral pentraxin-3, and miR-486-3p levels with postoperative recurrence and metastasis of colorectal cancer. APE1-AAbs: Apurinic/apyrimidinic endonuclease 1 autoantibodies; PTX-3: Peripheral pentraxin-3; CRC: Colorectal cancer.
Figure 3
Figure 3 Receiver operating characteristic curves of apurinic/apyrimidinic endonuclease 1 autoantibodies, peripheral pentraxin-3, and miR-486-3p levels alone and their combination for predicting postoperative recurrence and metastasis of colorectal cancer. APE1-AAbs: Apurinic/apyrimidinic endonuclease 1 autoantibodies; PTX-3: Peripheral pentraxin-3.